These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 26315832

  • 1. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A, Morris MJ, Kaboteh R, Båth L, Sadik M, Gjertsson P, Lomsky M, Edenbrandt L, Minarik D, Bjartell A.
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [Abstract] [Full Text] [Related]

  • 2. A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer.
    Reza M, Kaboteh R, Sadik M, Bjartell A, Wollmer P, Trägårdh E.
    BMC Med Imaging; 2018 May 04; 18(1):8. PubMed ID: 29728144
    [Abstract] [Full Text] [Related]

  • 3. A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.
    Anand A, Morris MJ, Kaboteh R, Reza M, Trägårdh E, Matsunaga N, Edenbrandt L, Bjartell A, Larson SM, Minarik D.
    J Nucl Med; 2016 Dec 04; 57(12):1865-1871. PubMed ID: 27445289
    [Abstract] [Full Text] [Related]

  • 4. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
    Takahashi Y, Yoshimura M, Suzuki K, Hashimoto T, Hirose H, Uchida K, Inoue S, Koizumi K, Tokuuye K.
    Ann Nucl Med; 2012 Aug 04; 26(7):586-93. PubMed ID: 22744807
    [Abstract] [Full Text] [Related]

  • 5. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.
    Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, Abrahamsson PA, Björk T, Gerdtsson A, Bjartell A, Gjertsson P, Höglund P, Lomsky M, Ohlsson M, Richter J, Sadik M, Morris MJ, Scher HI, Sjöstrand K, Yu A, Suurküla M, Edenbrandt L, Larson SM.
    Eur Urol; 2012 Jul 04; 62(1):78-84. PubMed ID: 22306323
    [Abstract] [Full Text] [Related]

  • 6. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.
    Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, Scher HI.
    Clin Cancer Res; 1998 Jul 04; 4(7):1765-72. PubMed ID: 9676853
    [Abstract] [Full Text] [Related]

  • 7. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (99mTc-HMDP) Bone Scintigraphy for Bone Metastases from Prostate Cancer Using Deep Learning Algorithms.
    Higashiyama S, Yoshida A, Kawabe J.
    Curr Med Imaging; 2021 Jul 04; 17(1):89-96. PubMed ID: 32484112
    [Abstract] [Full Text] [Related]

  • 8. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H, Nakajima K, Mizokami A, Namiki M, Inaki A, Taki J, Kinuya S.
    Ann Nucl Med; 2013 Nov 04; 27(9):802-7. PubMed ID: 23828554
    [Abstract] [Full Text] [Related]

  • 9. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
    Higashiyama S, Yoshida A, Kawabe J.
    Urol Int; 2022 Nov 04; 106(9):963-969. PubMed ID: 35249033
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
    Shintawati R, Achmad A, Higuchi T, Shimada H, Hirasawa H, Arisaka Y, Takahashi A, Nakajima T, Tsushima Y.
    Ann Nucl Med; 2015 Dec 04; 29(10):911-20. PubMed ID: 26373556
    [Abstract] [Full Text] [Related]

  • 11. Prospective evaluation of computer-assisted analysis of skeletal lesions for the staging of prostate cancer.
    Petersen LJ, Mortensen JC, Bertelsen H, Zacho HD.
    BMC Med Imaging; 2017 Jul 10; 17(1):40. PubMed ID: 28693433
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.
    Sabbatini P, Larson SM, Kremer A, Zhang ZF, Sun M, Yeung H, Imbriaco M, Horak I, Conolly M, Ding C, Ouyang P, Kelly WK, Scher HI.
    J Clin Oncol; 1999 Mar 10; 17(3):948-57. PubMed ID: 10071289
    [Abstract] [Full Text] [Related]

  • 13. Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials.
    Mota JM, Armstrong AJ, Larson SM, Fox JJ, Morris MJ.
    Prostate Cancer Prostatic Dis; 2019 Dec 10; 22(4):522-530. PubMed ID: 31036925
    [Abstract] [Full Text] [Related]

  • 14. Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer.
    Haupt F, Berding G, Namazian A, Wilke F, Böker A, Merseburger A, Geworski L, Kuczyk MA, Bengel FM, Peters I.
    Adv Ther; 2017 Apr 10; 34(4):986-994. PubMed ID: 28265811
    [Abstract] [Full Text] [Related]

  • 15. Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer.
    Saylor PJ, Mahmood U, Kunawudhi A, Smith MR, Palmer EL, Michaelson MD.
    J Nucl Med; 2012 Nov 10; 53(11):1670-5. PubMed ID: 22984218
    [Abstract] [Full Text] [Related]

  • 16. Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer.
    Poulsen MH, Rasmussen J, Edenbrandt L, Høilund-Carlsen PF, Gerke O, Johansen A, Lund L.
    BJU Int; 2016 May 10; 117(5):748-53. PubMed ID: 25906907
    [Abstract] [Full Text] [Related]

  • 17. Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.
    Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A, PROSTAT-BSI Investigators.
    Int J Urol; 2018 May 10; 25(5):492-499. PubMed ID: 29633398
    [Abstract] [Full Text] [Related]

  • 18. Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.
    Anand A, Morris MJ, Larson SM, Minarik D, Josefsson A, Helgstrand JT, Oturai PS, Edenbrandt L, Røder MA, Bjartell A.
    EJNMMI Res; 2016 Dec 10; 6(1):23. PubMed ID: 26960325
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).
    Armstrong AJ, Kaboteh R, Carducci MA, Damber JE, Stadler WM, Hansen M, Edenbrandt L, Forsberg G, Nordle Ö, Pili R, Morris MJ.
    Urol Oncol; 2014 Nov 10; 32(8):1308-16. PubMed ID: 25240761
    [Abstract] [Full Text] [Related]

  • 20. Scoring systems of quantitative bone scanning in prostate cancer: historical overview, current status and future perspectives.
    Zafeirakis A.
    Hell J Nucl Med; 2014 Nov 10; 17(2):136-44. PubMed ID: 24997079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.